DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Insomnia – Access & Reimbursement – Access & Reimbursement – Digital Therapeutics in Mental Health (US)
The rapid growth of digital therapeutic (DTx) solutions to treat medical problems, fueled by increased demand for telehealth services amid the COVID-19 pandemic, has tasked U.S. payers and pharmacy…
Schizophrenia | Unmet Need | Cognitive Impairment Associated with Schizophrenia | US/EU | 2022
According to Clarivate epidemiology, cognitive dysfunction (e.g., impaired attention / vigilance, memory, executive function) occurs in the vast majority of diagnosed schizophrenia patients and has…
Opioid Addiction – Current Treatment – Current Treatment: Physician Insights – Opioid Addiction (US)
Opioid addiction is a chronic disease, generally driven by a strong and irresistible urge or craving for the intake of opioid drugs and an inability to stop despite negative consequences to health…
Attention-Deficit/Hyperactivity Disorder | Treatment Algorithms: Claims Data Analysis | Pediatric | US | 2022
Attention-deficit-hyperactivity disorder (ADHD) is one of the most common childhood disorders that can continue into adulthood. For decades, childhood ADHD has been treated primarily with CNS…